[{"uuid": "c47e27d3-a966-3d18-8dd7-61fda60587a6", "title": "Cyclacel Pharmaceuticals Says David Lazar Buys $3.1 Million in Preferred Stock, Becomes Interim CEO", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/cyclacel-pharmaceuticals-says-david-lazar-154939594.html", "providerPublishTime": 1735919379, "type": "STORY", "relatedTickers": ["CYCC"]}, {"uuid": "9b034cd6-b0aa-34fc-b350-14a8bbcd7968", "title": "Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/cyclacel-pharmaceuticals-announces-agreement-acquisition-140100964.html", "providerPublishTime": 1735912860, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/PzmCMcUlTNEkCXgD6YUGCw--~B/aD02NTt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 174, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/euKxSTk1F.PBYwHlb2RsTA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CYCC", "CYCCP"]}, {"uuid": "b9e0028b-4ab8-3376-b9d1-7a714dc21ae6", "title": "Sector Update: Health Care Stocks Rise in Late Afternoon Trading", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-205803846.html", "providerPublishTime": 1735937883, "type": "STORY", "relatedTickers": ["NMRA"]}, {"uuid": "efb32c1d-e9b4-3b02-b3b2-71d0caea0666", "title": "Sector Update: Health Care", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-184229584.html", "providerPublishTime": 1735929749, "type": "STORY"}, {"uuid": "9e11c3b4-97b7-3e56-bf64-1105183893c2", "title": "Sector Update: Health Care Stocks Higher Friday Afternoon", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/sector-health-care-stocks-higher-185752957.html", "providerPublishTime": 1735930672, "type": "STORY", "relatedTickers": ["NMRA"]}, {"uuid": "8ecbedbf-a839-3ef7-9b2e-8d55eb1f65a9", "title": "Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q3 Loss", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/cyclacel-pharmaceuticals-inc-cycc-reports-230014272.html", "providerPublishTime": 1731452414, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781", "width": 900, "height": 600, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/p7XlvorZm6LARMpstyEGHA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CYCC"]}, {"uuid": "9e036c1d-7a56-3080-9567-fa415c78eca8", "title": "Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/cyclacel-pharmaceuticals-reports-third-quarter-214500428.html", "providerPublishTime": 1731447900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/PzmCMcUlTNEkCXgD6YUGCw--~B/aD02NTt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 174, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/euKxSTk1F.PBYwHlb2RsTA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CYCC", "CYCCP"]}, {"uuid": "9f52f8f9-4423-3aac-a1ee-92f608805f0e", "title": "Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/cyclacel-pharmaceuticals-announces-exploration-potential-210500537.html", "providerPublishTime": 1733432700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/PzmCMcUlTNEkCXgD6YUGCw--~B/aD02NTt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 174, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/euKxSTk1F.PBYwHlb2RsTA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CYCC", "CYCCP"]}, {"uuid": "a3bbb668-21b3-30c7-8c07-3fbb97c13852", "title": "Cyclacel Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/cyclacel-pharmaceuticals-third-quarter-2024-100653419.html", "providerPublishTime": 1731665213, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 945, "height": 636, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/NamfX5LEtyScIu4YmRG2hg--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CYCC", "CYCCP"]}, {"uuid": "a46f84c4-6043-389f-ab6a-51daba0722cc", "title": "Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/cyclacel-pharmaceuticals-announces-closing-exercise-211500254.html", "providerPublishTime": 1731618900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/PzmCMcUlTNEkCXgD6YUGCw--~B/aD02NTt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 174, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/euKxSTk1F.PBYwHlb2RsTA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CYCC", "CYCCP"]}, {"uuid": "f161e23a-de3c-3abe-8fb7-20d4045fc233", "title": "Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/cyclacel-pharmaceuticals-announces-exercise-warrants-172200906.html", "providerPublishTime": 1731518520, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/PzmCMcUlTNEkCXgD6YUGCw--~B/aD02NTt3PTE3NDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 174, "height": 65, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/euKxSTk1F.PBYwHlb2RsTA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/5d7add160421dcd95f81165ec986de4d", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["CYCC", "CYCCP"]}, {"uuid": "c10c2653-366f-3931-84b3-82e813585938", "title": "Adherex Technologies Inc. (FENC) Reports Q3 Loss, Misses Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/adherex-technologies-inc-fenc-reports-122506516.html", "providerPublishTime": 1730982306, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/6Ex_CnpNXcMseRWMhPXBow--~B/aD01ODg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94", "width": 900, "height": 588, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/FmoTNNnBcLLpLbaF2nY34Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94", "width": 140, "height": 140, "tag": "140x140"}]}}]